Eligibility Decisions Near For Australia’s New Provisional Pathway
Executive Summary
The first registration of a medicine under Australia’s new provisional approval pathway could take place at the end of this year, according to plans by the Therapeutic Goods Administration.
You may also be interested in...
Merck Scores A First With Keytruda Under Australia's Provisional Pathway
The Therapeutic Goods Administration has provisionally approved new uses of the anticancer medicine based on early clinical data.
Eli Lilly's Oncology Drug Is First Candidate For Australia's New Provisional Approval Pathway
Australia gets the ball rolling on its new pathway for provisional approval of innovative prescription medicines.
Australia’s Provisional Approval Pathway Prompts Industry Concerns Over Data Provision
Pharmaceutical industry responses to a consultation by Australia’s Therapeutic Goods Administration on a provisional approval pathway have revealed concerns over whether companies will be able to provide adequate data. Companies have also advised the TGA to look to other regulators, including the European Medicines Agency, for inspiration.